Recent Advances in Hepatitis B Treatment

Recent Advances in Hepatitis B Treatment

Hepatitis B virus infection affects over 250 million chronic carriers, causing more than 800,000 deaths annually, although a safe and effective vaccine is available. Currently used antiviral agents, pegylated interferon and nucleos(t)ide analogues, have major drawbacks and fail to completely eradica...

Full description

Bibliographic Details
Main Authors: Georgia-Myrto Prifti, Dimitrios Moianos, Erofili Giannakopoulou, Vasiliki Pardali, John E. Tavis, Grigoris Zoidis
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Pharmaceuticals
Subjects:
hepatitis B
hepatitis B virus
HBV
antiviral agents
HBV inhibitors
cccDNA
Online Access:https://www.mdpi.com/1424-8247/14/5/417

Internet

https://www.mdpi.com/1424-8247/14/5/417

Similar Items